The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Martin Nicholas and Nina Paleologos.
Connection Strength

0.158
  1. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma. J Clin Oncol. 2023 Nov 10; 41(32):4945-4952.
    View in: PubMed
    Score: 0.061
  2. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jun; 13(6):660-8.
    View in: PubMed
    Score: 0.026
  3. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Oncologist. 2010; 15(12):1329-34.
    View in: PubMed
    Score: 0.025
  4. Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jan; 13(1):143-51.
    View in: PubMed
    Score: 0.025
  5. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 Oct 01; 27(28):4733-40.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.